Sumitomo Mitsui Asset Management Company LTD Reduces Stake in Teleflex Incorporated (TFX)

Sumitomo Mitsui Asset Management Company LTD decreased its position in Teleflex Incorporated (NYSE:TFX) by 12.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,088 shares of the medical technology company’s stock after selling 455 shares during the period. Sumitomo Mitsui Asset Management Company LTD’s holdings in Teleflex were worth $641,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. UBS Asset Management Americas Inc. increased its position in shares of Teleflex by 118.9% in the fourth quarter. UBS Asset Management Americas Inc. now owns 72,560 shares of the medical technology company’s stock worth $11,692,000 after buying an additional 39,419 shares in the last quarter. Teachers Advisors LLC increased its position in shares of Teleflex by 4.8% in the fourth quarter. Teachers Advisors LLC now owns 45,560 shares of the medical technology company’s stock worth $7,342,000 after buying an additional 2,074 shares in the last quarter. Creative Planning boosted its stake in Teleflex by 3.7% in the first quarter. Creative Planning now owns 2,259 shares of the medical technology company’s stock worth $438,000 after buying an additional 81 shares during the last quarter. Pennsylvania Trust Co boosted its stake in Teleflex by 0.7% in the first quarter. Pennsylvania Trust Co now owns 2,165 shares of the medical technology company’s stock worth $419,000 after buying an additional 15 shares during the last quarter. Finally, Fox Run Management L.L.C. bought a new stake in Teleflex during the first quarter worth approximately $349,000. 92.59% of the stock is owned by institutional investors and hedge funds.

Teleflex Incorporated (TFX) traded down 0.59% on Friday, reaching $210.66. 174,889 shares of the company traded hands. The stock’s 50 day moving average price is $210.06 and its 200 day moving average price is $198.54. The company has a market capitalization of $9.49 billion, a PE ratio of 40.29 and a beta of 1.05. Teleflex Incorporated has a one year low of $136.53 and a one year high of $217.97.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, August 3rd. The medical technology company reported $2.04 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.91 by $0.13. Teleflex had a net margin of 12.36% and a return on equity of 16.12%. The company had revenue of $528.60 million for the quarter, compared to the consensus estimate of $518.98 million. During the same period in the prior year, the firm posted $1.89 EPS. Teleflex’s revenue for the quarter was up 11.6% on a year-over-year basis. On average, equities research analysts predict that Teleflex Incorporated will post $8.28 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 15th. Investors of record on Tuesday, August 15th will be given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.65%. The ex-dividend date of this dividend is Friday, August 11th. Teleflex’s dividend payout ratio (DPR) is 26.00%.

TRADEMARK VIOLATION WARNING: “Sumitomo Mitsui Asset Management Company LTD Reduces Stake in Teleflex Incorporated (TFX)” was originally published by Community Financial News and is the property of of Community Financial News. If you are viewing this news story on another site, it was illegally stolen and republished in violation of United States & international trademark and copyright laws. The original version of this news story can be viewed at https://www.com-unik.info/2017/08/19/teleflex-incorporated-tfx-shares-sold-by-sumitomo-mitsui-asset-management-company-ltd-updated.html.

TFX has been the subject of a number of research reports. Barclays PLC restated a “buy” rating on shares of Teleflex in a report on Monday, June 26th. Deutsche Bank AG reiterated a “buy” rating and set a $238.00 price objective (up from $220.00) on shares of Teleflex in a report on Wednesday, August 9th. Needham & Company LLC reiterated a “buy” rating on shares of Teleflex in a report on Friday, August 4th. Zacks Investment Research upgraded shares of Teleflex from a “hold” rating to a “buy” rating and set a $228.00 price objective for the company in a report on Friday, June 23rd. Finally, BidaskClub cut shares of Teleflex from a “hold” rating to a “sell” rating in a report on Tuesday, August 8th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and six have given a buy rating to the company’s stock. Teleflex presently has a consensus rating of “Buy” and a consensus price target of $228.00.

In related news, Director Gretchen R. Haggerty purchased 1,000 shares of the company’s stock in a transaction dated Wednesday, June 21st. The shares were purchased at an average price of $203.82 per share, with a total value of $203,820.00. Following the acquisition, the director now directly owns 1,760 shares in the company, valued at approximately $358,723.20. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Stephen K. M.D. Klasko sold 200 shares of the firm’s stock in a transaction dated Thursday, June 1st. The shares were sold at an average price of $199.93, for a total transaction of $39,986.00. Following the sale, the director now directly owns 8,080 shares in the company, valued at approximately $1,615,434.40. The disclosure for this sale can be found here. Insiders have sold a total of 3,100 shares of company stock worth $637,463 over the last three months. 2.39% of the stock is currently owned by insiders.

Teleflex Company Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

What are top analysts saying about Teleflex Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Teleflex Incorporated and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit